Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Asian Bioethics Review|October 13, 2025
"Your Tumour Can Save Lives": Re-examining Singapore's Consent Procedures for the Use of De-identified Bio-specimens in ResearchKylie J Q Heng, Shaun S E Loong, Gini W W Wong, et al.Journal of Hypertension|March 21, 2024
Unique characteristics of Asians with hypertension: what is known and what can be done?Germaine Loo, Troy Puar, Roger Foo, et al.Frontiers in Cardiovascular Medicine|March 14, 2022
Design Variation, Implantation, and Outcome of Transcatheter Mitral Valve Prosthesis: A Comprehensive ReviewFaizus Sazzad, Jimmy Kim Fatt Hon, Kollengode Ramanathan, et al.Frontiers in Endocrinology|August 6, 2025
Lipoprotein(a) as a predictor of mortality in hospitalised patients with ischaemic heart diseaseWann Jia Loh, Xuan Han Koh, Colin Yeo, et al.Genome Medicine|June 16, 2010
High-throughput sequencing identifies STAT3 as the DNA-associated factor for p53-NF-kappaB-complex-dependent gene expression in human heart failureMun-Kit Choy, Mehregan Movassagh, Lee Siggens, et al.European Journal of Preventive Cardiology|February 19, 2025
Global Prevalence of Myocardial Fibrosis among Individuals with Cardiometabolic Conditions: A Systematic Review and Meta-AnalysisTin Mei Yeo, Woon Loong Calvin Chin, Chuen Wei Alvin Seah, et al.Channels (Austin, Tex.)|September 27, 2017
Characterization of CaV1.2 exon 33 heterozygous knockout mice and negative correlation between Rbfox1 and CaV1.2 exon 33 expressions in human heart failureJuejin Wang, Guang Li, Dejie Yu, et al.Scientific Reports|October 13, 2016
Aberrant Splicing Promotes Proteasomal Degradation of L-type CaV1.2 Calcium Channels by Competitive Binding for CaVβ Subunits in Cardiac HypertrophyZhenyu Hu, Jiong-Wei Wang, Dejie Yu, et al.Stem Cell Reports|July 2, 2021
Ethics and regulatory considerations for the clinical translation of somatic cell human epigenetic editingNikolajs Zeps, Tamra Lysaght, Ruth Chadwick, et al.Frontiers in Genetics|August 29, 2022
The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseasesNicholas W S Chew, Bryan Chong, Cheng Han Ng, et al.Pageof 11